Condition: Prostate Cancer (Adenocarcinoma) · Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
The goal of this observational study is to assess the chance to predict prostate cancer with the analysis of specific values found in images obtained from RMmp (multiparametric magnetic resonance imaging) of patients who went through the procedure at IRCCS Azienda Ospedaliero-Universitaria hospital in the city of Bologna from September 2015 to March 2021. The main question it aims to answer is: \- does the analysis of ADC values and radiomics values found in the RMmp images help with the detection of prostate cancer?
This description comes directly from the study's public registry record.
Caterina Gaudiano, MD · +39 0515142307 · caterina.gaudiano@aosp.bo.it
Always discuss trial participation with your own doctor first.
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | Bologna, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06774781